Comparison of two point-of-care international normalized ratio devices and laboratory method

: A number of factors contribute to interlaboratory variation of international normalized ratio (INR) results. This variability can lead to differences in clinical decision-making. This prospective cohort study evaluated the accuracy, precision, and clinical decision-making variability of two point-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood coagulation & fibrinolysis 2017-10, Vol.28 (7), p.534-539
Hauptverfasser: Vazquez, Sara R, Fleming, Ryan P, Johnson, Stacy A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:: A number of factors contribute to interlaboratory variation of international normalized ratio (INR) results. This variability can lead to differences in clinical decision-making. This prospective cohort study evaluated the accuracy, precision, and clinical decision-making variability of two point-of-care (POC) devices (CoaguChek XS and the Coag-Sense) to a clinical laboratory method of INR measurement as the 'reference' and by using the laboratory's accuracy standard (±25% of the reference INR). Study subjects included adults taking warfarin undergoing a POC INR with each device and a laboratory INR on the same day and evaluated differences in clinical decision-making using a warfarin nomogram. A correction factor was derived for each POC method to estimate the corresponding laboratory INR for POC INRs more than 3.0. A total of 100 patient encounters (76 unique patients) included INR testing by all three methods. Both POC devices demonstrated excellent precision across the entire range (r = 0.98), but poor accuracy relative to the laboratory standard for POC INRs greater than 3.0 (accuracy CoaguChek 19% and Coag-Sense 35%). A correction factor applied to POC INRs greater than 3.0 improved accuracy to 99% for both devices. Applying the correction factor also significantly reduced differences in clinical decision-making (49-28% for CoaguChek and 56-40% for Coag-Sense, P 
ISSN:0957-5235
1473-5733
DOI:10.1097/MBC.0000000000000633